SL
Steven W Lefkowitz
Director

Steven W Lefkowitz insider trades: CorMedix (CRMD) stock buys and sales

Director, CorMedix Last trade Dec 9, 2025 57 Form 4 filings
$475K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
16
Open-market trades
since 2005
5
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Steven reports to the SEC

Open-market buys and sales

16 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 9, 2025CRMD↓ Sell$475K
Sep 4, 2020CRMD↑ Buy$23K
Sep 27, 2019CRMD↑ Buy$34K
Dec 20, 2018CRMD↑ Buy$24K
Dec 12, 2017CRMD↑ Buy$65K
May 31, 2016CRMD↓ Sell$144K
May 23, 2016CRMD↓ Sell$88K
Jun 1, 2015CRMD↓ Sell$255K
Dec 16, 2013CRMD↑ Buy$14K
Aug 27, 2013FCRM↓ Sell$3K
Aug 23, 2013FCRM↓ Sell$17K
Dec 16, 2011CRMD↑ Buy$5K
Dec 30, 2010FCMC↓ Sell$4K
Sep 27, 2006FCMC↑ Buy$28K
Apr 28, 2006FCMC↑ Buy$70K
Jun 16, 2005FCSC↑ Buy$59K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CRMD insiders

Open-market trades in the last 12 months

About Steven W Lefkowitz's insider trades

Steven W Lefkowitz is a director at CorMedix (CRMD). Since Jun 16, 2005, Steven has reported 9 open-market purchases worth $320K and 7 sales worth $986K on SEC Form 4. In the last 12 months: 1 sale ($475K).

Their filings also include grants and awards (27 filings), option exercises (12 filings), other transactions (7 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.